Maria de Fatima Falangola
Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 4 | 2022 | 565 | 1.520 |
Why?
|
| White Matter | 3 | 2021 | 174 | 1.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 237 | 0.810 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2022 | 239 | 0.790 |
Why?
|
| Basal Forebrain | 1 | 2021 | 15 | 0.770 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2021 | 211 | 0.730 |
Why?
|
| Image Enhancement | 2 | 2014 | 143 | 0.570 |
Why?
|
| Brain | 3 | 2022 | 2176 | 0.540 |
Why?
|
| Corpus Callosum | 1 | 2014 | 29 | 0.480 |
Why?
|
| Demyelinating Diseases | 1 | 2014 | 57 | 0.480 |
Why?
|
| Down Syndrome | 1 | 2014 | 120 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 333 | 0.380 |
Why?
|
| Cognitive Dysfunction | 2 | 2013 | 176 | 0.380 |
Why?
|
| Aging | 1 | 2014 | 911 | 0.320 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 1033 | 0.280 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.230 |
Why?
|
| Equidae | 1 | 2022 | 3 | 0.220 |
Why?
|
| Animals | 6 | 2022 | 20880 | 0.210 |
Why?
|
| Cholinergic Agents | 1 | 2021 | 12 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 191 | 0.190 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1753 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2077 | 0.160 |
Why?
|
| Algorithms | 2 | 2014 | 1195 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 2791 | 0.150 |
Why?
|
| Diet, Western | 1 | 2016 | 17 | 0.140 |
Why?
|
| Anesthetics | 1 | 2016 | 30 | 0.140 |
Why?
|
| Midazolam | 1 | 2016 | 46 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2550 | 0.120 |
Why?
|
| Sensorimotor Cortex | 1 | 2015 | 18 | 0.120 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 134 | 0.120 |
Why?
|
| Cuprizone | 1 | 2014 | 3 | 0.120 |
Why?
|
| Gray Matter | 1 | 2015 | 57 | 0.120 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.120 |
Why?
|
| Diffusion | 1 | 2014 | 90 | 0.120 |
Why?
|
| Aged | 3 | 2022 | 14842 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 306 | 0.110 |
Why?
|
| Myelin Sheath | 1 | 2013 | 115 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2013 | 46 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 70 | 0.110 |
Why?
|
| Hippocampus | 1 | 2016 | 471 | 0.110 |
Why?
|
| Male | 6 | 2016 | 37283 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 329 | 0.100 |
Why?
|
| Humans | 3 | 2022 | 68549 | 0.050 |
Why?
|
| Stroke | 1 | 2015 | 2162 | 0.050 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 11 | 0.030 |
Why?
|
| Voltage-Dependent Anion Channel 2 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 104 | 0.030 |
Why?
|
| Maze Learning | 1 | 2016 | 138 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 242 | 0.030 |
Why?
|
| Female | 2 | 2013 | 38021 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2015 | 203 | 0.030 |
Why?
|
| Body Weight | 1 | 2016 | 554 | 0.030 |
Why?
|
| Semantics | 1 | 2013 | 37 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 517 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1860 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 782 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 689 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1641 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 5300 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 2222 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 4843 | 0.010 |
Why?
|